These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31293710)

  • 1. Inappropriate implantable cardioverter defibrillator shocks due to atrial far-field on the tip-to-ring channel for lead dislodgement.
    Ferretto S; Brunzin K; Pettenuzzo K; Nangah Suh R; Canali C; Di Pede F
    J Arrhythm; 2019 Jun; 35(3):562-564. PubMed ID: 31293710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Life-threatening and life-saving inappropriate implantable cardioverter defibrillator shocks.
    Pérez-Rodon J; Doiny D; Miranda B; Rivas-Gandara N; Roca-Luque I; Francisco-Pascual J; Lidón RM; García-Dorado D; Moya Mitjans A
    Clin Case Rep; 2017 Apr; 5(4):521-525. PubMed ID: 28396781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.
    Powell BD; Saxon LA; Boehmer JP; Day JD; Gilliam FR; Heidenreich PA; Jones PW; Rousseau MJ; Hayes DL
    J Am Coll Cardiol; 2013 Oct; 62(18):1674-1679. PubMed ID: 23810882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial.
    Knops RE; van der Stuijt W; Delnoy PPHM; Boersma LVA; Kuschyk J; El-Chami MF; Bonnemeier H; Behr ER; Brouwer TF; Kääb S; Mittal S; Quast ABE; Smeding L; Tijssen JGP; Bijsterveld NR; Richter S; Brouwer MA; de Groot JR; Kooiman KM; Lambiase PD; Neuzil P; Vernooy K; Alings M; Betts TR; Bracke FALE; Burke MC; de Jong JSSG; Wright DJ; Jansen WPJ; Whinnet ZI; Nordbeck P; Knaut M; Philbert BT; van Opstal JM; Chicos AB; Allaart CP; Borger van der Burg AE; Clancy JF; Dizon JM; Miller MA; Nemirovsky D; Surber R; Upadhyay GA; Weiss R; de Weger A; Wilde AAM; Olde Nordkamp LRA;
    Circulation; 2022 Feb; 145(5):321-329. PubMed ID: 34779221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Parameters of cardiac pacing and effectiveness of defibrillation during implantable cardioverter-defibrillator lead implantation to right ventricle outflow tract].
    Rydlewska A; Machejek J; Engel A; Lelakowski J
    Pol Merkur Lekarski; 2013 Nov; 35(209):254-8. PubMed ID: 24575643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Case of 25 Inappropriate Automatic Implantable Cardioverter Defibrillator Shocks and 22 Episodes of Antitachycardia Pacing.
    Morrison N; Voleti N; Cannizzaro M
    Cureus; 2023 Mar; 15(3):e35634. PubMed ID: 37009346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons learned from data logging in a multicenter clinical trial using a late-generation implantable cardioverter-defibrillator. The Guardian ATP 4210 Multicenter Investigators Group.
    Wood MA; Stambler BS; Damiano RJ; Greenway P; Ellenbogen KA
    J Am Coll Cardiol; 1994 Dec; 24(7):1692-9. PubMed ID: 7963117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of abortive shock capability with electrogram storage in cardioverter-defibrillator devices.
    Hurwitz JL; Hook BG; Flores BT; Marchlinski FE
    J Am Coll Cardiol; 1993 Mar; 21(4):895-900. PubMed ID: 8450157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablation of atrial fibrillation in Brugada syndrome patients with an implantable cardioverter defibrillator to prevent inappropriate shocks resulting from rapid atrial fibrillation.
    Sairaku A; Yoshida Y; Nakano Y; Kihara Y
    Int J Cardiol; 2013 Oct; 168(6):5273-6. PubMed ID: 23988302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and testing of an algorithm to detect implantable cardioverter-defibrillator lead failure.
    Gunderson BD; Gillberg JM; Wood MA; Vijayaraman P; Shepard RK; Ellenbogen KA
    Heart Rhythm; 2006 Feb; 3(2):155-62. PubMed ID: 16443529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy).
    Ruwald MH; Abu-Zeitone A; Jons C; Ruwald AC; McNitt S; Kutyifa V; Zareba W; Moss AJ
    J Am Coll Cardiol; 2013 Oct; 62(15):1343-50. PubMed ID: 23770172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study.
    Kolb C; Sturmer M; Sick P; Reif S; Davy JM; Molon G; Schwab JO; Mantovani G; Dan D; Lennerz C; Borri-Brunetto A; Babuty D
    JACC Heart Fail; 2014 Dec; 2(6):611-9. PubMed ID: 25282033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downloadable algorithm to reduce inappropriate shocks caused by fractures of implantable cardioverter-defibrillator leads.
    Swerdlow CD; Gunderson BD; Ousdigian KT; Abeyratne A; Stadler RW; Gillberg JM; Patel AS; Ellenbogen KA
    Circulation; 2008 Nov; 118(21):2122-9. PubMed ID: 18981299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Transatlantic Experience.
    Orgeron GM; Bhonsale A; Migliore F; James CA; Tichnell C; Murray B; Bertaglia E; Cadrin-Tourigny J; De Franceschi P; Crosson J; Tandri H; Corrado D; Calkins H
    J Am Heart Assoc; 2018 Nov; 7(21):e008782. PubMed ID: 30608223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter investigation of an implantable cardioverter-defibrillator algorithm to detect oversensing.
    Welte N; Strik M; Eschalier R; Mondoly P; Defaye P; Frontera A; Ritter P; Haïssaguerre M; Ploux S; Koneru J; Ellenbogen KA; Bordachar P
    Heart Rhythm; 2017 Jul; 14(7):1008-1015. PubMed ID: 28323174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Shocking Case of Far-Field Atrial Oversensing in Giant-Cell Myocarditis.
    Datta T; Melnick S; Rajaram B; Pavri BB
    JACC Case Rep; 2021 Apr; 3(4):603-609. PubMed ID: 34317586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitachycardia pacing programming in implantable cardioverter defibrillator: A systematic review.
    De Maria E; Giacopelli D; Borghi A; Modonesi L; Cappelli S
    World J Cardiol; 2017 May; 9(5):429-436. PubMed ID: 28603590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of Electromechanical Coupling to Prevent Inappropriate Implantable Cardioverter-Defibrillator Shocks.
    Keene D; Shun-Shin MJ; Arnold AD; Howard JP; Lefroy D; Davies DW; Lim PB; Ng FS; Koa-Wing M; Qureshi NA; Linton NWF; Shah JS; Peters NS; Kanagaratnam P; Francis DP; Whinnett ZI
    JACC Clin Electrophysiol; 2019 Jun; 5(6):705-715. PubMed ID: 31221358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated subcutaneous implantable cardioverter-defibrillator generator displacement causing inappropriate shocks despite preserved lead tip and coil position: a case report.
    Chow JJ; Bilham J; Lane R
    Eur Heart J Case Rep; 2023 Feb; 7(2):ytad023. PubMed ID: 36755787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An unusual mechanism causing inappropriate implantable cardioverter defibrillator shocks: transient reduction in R-wave amplitude.
    Baranchuk A; Ribas S; Divakaramenon S; Morillo CA
    Europace; 2007 Aug; 9(8):694-6. PubMed ID: 17478463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.